SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-283334
Filing Date
2019-11-04
Accepted
2019-11-04 16:05:36
Documents
3
Period of Report
2019-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d830272d8k.htm 8-K 19420
2 EX-99.1 d830272dex991.htm EX-99.1 81749
3 GRAPHIC g830272g07h87.jpg GRAPHIC 3192
  Complete submission text file 0001193125-19-283334.txt   106906
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 191189777
SIC: 2834 Pharmaceutical Preparations